• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is the treatment of hepatocellular carcinoma on the waiting list necessary?

作者信息

Majno Pietro, Lencioni Riccardo, Mornex Françoise, Girard Nicolas, Poon Ronnie T, Cherqui Daniel

机构信息

Department of Transplantation and Visceral Surgery, University Hospital of Geneva, Geneva, Switzerland.

出版信息

Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391.

DOI:10.1002/lt.22391
PMID:21954097
Abstract
摘要

相似文献

1
Is the treatment of hepatocellular carcinoma on the waiting list necessary?等待名单上的肝细胞癌患者是否需要治疗？
Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391.
2
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?肝细胞癌降期后患者是否符合肝移植条件？
Liver Transpl. 2011 Oct;17 Suppl 2:S109-16. doi: 10.1002/lt.22335.
3
Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.用于监测等待肝移植及肝移植后肝细胞癌患者的工具。
Liver Transpl. 2011 Oct;17 Suppl 2:S117-27. doi: 10.1002/lt.22334.
4
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.肝细胞癌患者在等待肝移植期间先进行化疗栓塞可延缓肿瘤进展，并带来良好的预后。
Liver Transpl. 2003 Jun;9(6):557-63. doi: 10.1053/jlts.2003.50106.
5
Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.优化肝细胞癌原位肝移植适应证。
Liver Transpl. 2011 Oct;17 Suppl 2:S6-13. doi: 10.1002/lt.22423.
6
Hepatocellular carcinoma and liver transplantation.肝细胞癌与肝移植。
Curr Opin Organ Transplant. 2011 Jun;16(3):297-300. doi: 10.1097/MOT.0b013e3283465756.
7
Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.等待肝移植期间肝细胞癌的进展
Transplantation. 2015 Sep;99(9):e155-6. doi: 10.1097/TP.0000000000000826.
8
Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?在活体肝移植失败后，我们是否应该进行尸体供肝移植？
Liver Transpl. 2011 Oct;17 Suppl 2:S139-46. doi: 10.1002/lt.22328.
9
Is tumor biopsy necessary?肿瘤活检有必要吗？
Liver Transpl. 2011 Oct;17 Suppl 2:S14-25. doi: 10.1002/lt.22374.
10
General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?肝移植前新辅助治疗肝细胞癌的概述：必要性还是选择？
Liver Int. 2011 Sep;31(8):1081-9. doi: 10.1111/j.1478-3231.2011.02473.x.

引用本文的文献

1
Predicting waitlist dropout in hepatocellular carcinoma: a narrative review.预测肝细胞癌患者在等待名单上的退出情况：一项叙述性综述。
Transl Gastroenterol Hepatol. 2024 Aug 21;9:72. doi: 10.21037/tgh-24-24. eCollection 2024.
2
Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology.肝细胞癌：免疫疗法与移植在移植肿瘤学时代的作用
Cancers (Basel). 2023 Oct 24;15(21):5115. doi: 10.3390/cancers15215115.
3
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
索拉非尼联合肝动脉灌注化疗治疗晚期肝细胞癌的系统评价和荟萃分析。
Turk J Gastroenterol. 2023 Apr;34(4):311-321. doi: 10.5152/tjg.2023.22383.
4
Recent update on comprehensive therapy for advanced hepatocellular carcinoma.晚期肝细胞癌综合治疗的最新进展
World J Gastrointest Oncol. 2021 Aug 15;13(8):845-855. doi: 10.4251/wjgo.v13.i8.845.
5
Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.可降解淀粉微球经动脉化疗栓塞术作为早期肝细胞癌且符合肝移植标准的Child-Pugh B级患者的桥接治疗的安全性和有效性
Front Pharmacol. 2021 Apr 9;12:634084. doi: 10.3389/fphar.2021.634084. eCollection 2021.
6
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.沙特肝脏疾病与移植研究协会肝细胞癌诊断与管理实践指南
Saudi J Gastroenterol. 2020 Oct;26(Suppl 1):S1-S40. doi: 10.4103/sjg.SJG_477_20.
7
Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma.在肝细胞癌新辅助肝移植治疗中，药物洗脱微球化疗栓塞后的影像反应预测指标
World J Hepatol. 2020 Jan 27;12(1):21-33. doi: 10.4254/wjh.v12.i1.21.
8
Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.接受经导管肝动脉化疗栓塞术桥接或降期治疗的肝细胞癌的长期结局。
World J Gastroenterol. 2019 Oct 7;25(37):5687-5701. doi: 10.3748/wjg.v25.i37.5687.
9
Liver transplantation for hepatocellular carcinoma: Where do we stand?肝移植治疗肝细胞癌：我们处于什么位置？
World J Gastroenterol. 2019 Jun 7;25(21):2591-2602. doi: 10.3748/wjg.v25.i21.2591.
10
When to consider liver transplantation in hepatocellular carcinoma patients?肝细胞癌患者何时应考虑肝移植？
Hepat Oncol. 2017 Jan;4(1):15-24. doi: 10.2217/hep-2016-0010. Epub 2017 Jul 6.